1. Prognosis of Gastrointestinal Smooth-Muscle (Stromal) Tumors
2. Myosarcomas of the stomach: Natural history, prognostic factors and management
3. Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
4. Blanke CD, Von Mehren M, Joensuu H, et al: Evaluation of the safety and efficacy of an oral molecularly targeted therapy, STI 571, in patients with unresectable or metastatic gastrointestinal stromal tumors (GIST) expressing C-KIT (CD117). Proc Am Soc Clin Oncol 20: 1a,2001 (abstr 1)
5. Van Oosterom AT, Judson I, Verweij E, et al: STI 571, an active drug in metastatic gastrointestinal stromal tumors (GIST), an EORTC phase I study. Proc Am Soc Clin Oncol 20: 1a,2001 (abstr 2)